Our Global Life Sciences M&A team were invited by Financier Worldwide, a leading, widely respected information source covering corporate finance and board-level business issues to provide their views on the life sciences M&A market for the upcoming November issue. The topics covered in the Q&A include deal appetite, regulatory changes, FDI, managing transactional risk, pre and post deal strategies, and the future of the market.
***************
This article was first published by Financier Worldwide Ltd
©2023 Financier Worldwide Ltd. All rights reserved.
Permission to use this reprint has been granted by the publisher.
***************
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-10-08-10-50-28-575-67050e74c71f57809f6d0411.jpg)
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-11-19-11-18-14-682-673c73f69e69c3dc65f3f6d9.jpg)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-11-19-12-42-49-261-673c87c925126ee9da0a18fc.jpg)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-11-05-09-46-46-710-6729e986fa0caa16109ca90f.jpg)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Document/2024-11-05-09-42-20-904-A25696_Life_Sciences_Brochure_OctoberEN_Brochure_V2_FINAL_thumbnail_1.png)
